LakeShore Biopharma Co., Ltd: income_tax_expense
| Value | {"amount": -3062524, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} |
|---|---|
| Period | 2023-04-01 – 2024-03-31 |
| Status | current |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/873104c3-6a7f-4fc7-ad93-2895a9c733b3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-069344Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/income-tax-expense/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/873104c3-6a7f-4fc7-ad93-2895a9c733b3
History
- supersedes {"unit": "CNY", "value": -21728607, "concept": "us-gaap:IncomeTaxExpenseBenefit"} (evidence 0001213900-24-069344)